MDMG opens multi-disciplinary hospital in Tyumen

MD Medical Group opens new multi-disciplinary hospital in Tyumen

8 April 2019, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, announces that it has opened a new multi-disciplinary hospital in Tyumen.

The hospital's construction began at the end of Q2 2017 and was completed according to schedule. The Group's total investment in the project amounted to 3.2 billion roubles. This is one of the largest healthcare projects in the Tyumen Region.

The new 15,000 sq m hospital offers both the Group's core services as well as a wide range of other medical services for all family members. It provides services in more than 20 medical areas, such as OBGYN, IVF (including under the Mandatory Health Insurance programme), urology, surgery, orthopaedics, cardiology, endovascular surgery, plastic surgery, laboratory diagnostics, and more.

The multi-disciplinary hospital has 10 high-tech operating theatres including an integrated facility that allows for remote consultations with doctors at other MDMG facilities to take place.

The hospital's state-of-the-art equipment enables the doctors to carry out various surgical operations, such as endoscopic ENT and low-trauma endoscopic operations, traumatologic operations, a wide range of urologic operations, all kinds of laparoscopic procedures in gynaecology, oncological gynaecology, etc. The hospital is capable of carrying out unique organ-sparing surgeries using endovascular technologies and will be developing the foetal medicine, including foetal surgery.

The hospital's diagnostics centre offers an extensive range of services including CT, MRI, mammography, X-ray and ultrasound diagnostics, and angiography. It will also have an endoscopy department and a diagnostics laboratory capable of carrying out research in eight areas, including genetic testing, PCR, and oncologic cytology.

The new Tyumen hospital demonstrates the Group's continued commitment to building multi-functional medical centres based on its standard design model in the Russian regions. The new 6-storey hospital has 164 beds and annual capacity of up to 2,500 deliveries, up to 1,200 IVF cycles, 220,000 out-patient visits and 8,500 surgical operations.

The hospital will operate in line with MD Medical Group's customary high standard of medical care and is fitted with world-class equipment produced by GE Healthcare, Olympus, Origio, OxfordMedical, Draeger, Storz, Philips, RocketMedical and ZOLL MedicalCorporation.

Mark Kurtser, CEO of MD Medical Group, said:

"Only a year after the successful launch of our new hospital in Samara, we are opening our second standard regional hospital - this time in Tyumen, the oil capital of Russia and one of the fastest-developing cities in the country.

"We highly appreciate the extensive support provided by the government of the Tyumen Region at all stages of the hospital's development. With the opening of this new hospital, the Company is following its regional development strategy aimed at offering technologically advanced medical care to patients in an increasing number of Russian regions. At the same time, we are expanding the use of modern medical technologies, creating new jobs, contributing to improving the quality of life and building the foundation for our future growth."

About the Tyumen region

The Tyumen Region has a population of 3.724 million people, over 80% of which live in cities. As the region's largest city and administrative centre, Tyumen has approximately 768,000 inhabitants. The region benefits from high birth rates - around 20,000 children are born in the region annually. In 2017, there were 14.4 births per thousand inhabitants, placing the region in the top 10 in this respect among all Russian regions.

For further information please contact:

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, and Vladivostok.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.